Hepatitis B virus (HBV) and hepatocellular carcinoma (HCC) in sub-Saharan Africa: no room for complacency

• 作者: Philippa C.Matthews Anna Kramvis
• 来源期刊: 肝癌研究（英文版）
• 年，卷（期）: 2022,（3）
• 所属期刊栏目: Editorial
• 页码范围: 57-61
• 页数: 5页
• 语种: 英文
• DOI: 10.20517/2394-5079.2022.11

摘要

The increasing incidence and mortality of hepatocellular carcinoma (HCC) driven by hepatitis B virus (HBV) infection is a global public health concern[1]. Despite World Health Organization (WHO) targets for the elimination of hepatitis as a public health problem by 2030, death attributable to viral hepatitis has continued to rise over the past decade[2], in contrast to the reduction seen in the comparable threats of human immunodeficiency virus (HIV), tuberculosis (TB) and malaria.